TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Colorado Institutions Vying to Build First Carbon Ion Center in the U.S. September 26, 2014